» Articles » PMID: 7608249

Expression of Pit-1 Messenger Ribonucleic Acid and Protein in the Human Placenta

Overview
Specialty Endocrinology
Date 1995 Jul 1
PMID 7608249
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that the human placenta produces a wide range of hormones similar to those secreted by the pituitary and hypothalamus. However, the physiological role and regulation of placental hormone synthesis and release are still largely unknown. GH (GH-N) is expressed in the pituitary, where it requires the tissue-specific transcription factor Pit-1. Chorionic somatomammotropin A (CS-A) and CS-B as well as the placental GH variant (GH-V), which also belong to the GH gene family and are located in the same chromosomal cluster, are expressed in the placental syncytiotrophoblast. The presence of Pit-1-binding sites in the CS-A and GH-V promoter regions predicts that Pit-1 may be expressed in the placenta. However, this has not yet been demonstrated. To examine possible similarities in the regulation of these genes in the pituitary and placenta, we studied the expression of pit-1 messenger ribonucleic acid (mRNA) in the human placenta, transformed human placental cells, and the JEG-3 choriocarcinoma cell line. Polymerase chain reaction (PCR) products of the expected size were amplified from first and third trimester placentas, transformed placental cells, and JEG-3 complementary DNA by reverse transcription-PCR. The pit-1-specific sequence was confirmed by restriction endonuclease digestion, Southern hybridization, and DNA sequencing. Human pituitary tissue was used as a positive control; no PCR product was obtained from hippocampus (negative control). In situ hybridization of placental tissue sections revealed the presence of pit-1 mRNA in first and third trimester syncytiotrophoblast. Pit-1 protein was localized by immunohistochemistry with the same tissue distribution and a nuclear localization pattern. These data demonstrate expression of pit-1 mRNA and Pit-1 protein in the human placenta, thus questioning its role as a pituitary-specific regulator of GH-N gene transcription. The expression of Pit-1 in the placenta, together with its previously demonstrated capability to bind to and activate the CS-A and the GH-V promoters, suggests that it may play a role in the regulation of hormones belonging to the GH gene family in both pituitary and placenta.

Citing Articles

Multilineage Pituitary Neuroendocrine Tumors Expressing TPIT and SF1: A Clinicopathological Series of Six Tumors.

Asa S, Faiman G, Mohamed A, Mete O Endocr Pathol. 2024; 35(4):349-353.

PMID: 39579326 DOI: 10.1007/s12022-024-09841-0.


Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients.

Gao Z, Xue K, Zhang L, Wei M Med Sci Monit. 2016; 22:4121-4125.

PMID: 27798557 PMC: 5094475. DOI: 10.12659/msm.896107.


CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Tong Y, Zhou J, Mizutani J, Fukuoka H, Ren S, Gutierrez-Hartmann A Mol Endocrinol. 2011; 25(11):1880-91.

PMID: 21980073 PMC: 3198962. DOI: 10.1210/me.2011-1075.


Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis.

Ben-Batalla I, Seoane S, Garcia-Caballero T, Gallego R, Macia M, Gonzalez L J Clin Invest. 2010; 120(12):4289-302.

PMID: 21060149 PMC: 2993584. DOI: 10.1172/JCI42015.


The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.

Ben-Batalla I, Seoane S, Macia M, Garcia-Caballero T, Gonzalez L, Vizoso F Endocr Relat Cancer. 2009; 17(1):73-85.

PMID: 19808898 PMC: 2828808. DOI: 10.1677/ERC-09-0100.